216 related articles for article (PubMed ID: 32532990)
41. [Cloning,expression and activity identification of human innate immune protein apolipoprotein B mRNA editing enzyme catalytic subunit 3A(APOBEC3A)].
Cheng S; Cao L; Du J; Wang W; Guo Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):179-84. PubMed ID: 29762985
[TBL] [Abstract][Full Text] [Related]
42. APOBEC3A Expression in Penile Squamous Cell Carcinoma.
Heller M; Prigge ES; Kaczorowski A; von Knebel Doeberitz M; Hohenfellner M; Duensing S
Pathobiology; 2018; 85(3):169-178. PubMed ID: 29166639
[TBL] [Abstract][Full Text] [Related]
43. Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A.
Harjes S; Kurup HM; Rieffer AE; Bayarjargal M; Filitcheva J; Su Y; Hale TK; Filichev VV; Harjes E; Harris RS; Jameson GB
Nat Commun; 2023 Oct; 14(1):6382. PubMed ID: 37821454
[TBL] [Abstract][Full Text] [Related]
44. Herpes Simplex Virus Type 1 Infection Disturbs the Mitochondrial Network, Leading to Type I Interferon Production through the RNA Polymerase III/RIG-I Pathway.
Berry N; Suspène R; Caval V; Khalfi P; Beauclair G; Rigaud S; Blanc H; Vignuzzi M; Wain-Hobson S; Vartanian JP
mBio; 2021 Dec; 12(6):e0255721. PubMed ID: 34809467
[TBL] [Abstract][Full Text] [Related]
45. Cas12a Base Editors Induce Efficient and Specific Editing with Low DNA Damage Response.
Wang X; Ding C; Yu W; Wang Y; He S; Yang B; Xiong YC; Wei J; Li J; Liang J; Lu Z; Zhu W; Wu J; Zhou Z; Huang X; Liu Z; Yang L; Chen J
Cell Rep; 2020 Jun; 31(9):107723. PubMed ID: 32492431
[TBL] [Abstract][Full Text] [Related]
46. A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.
Siriwardena SU; Perera MLW; Senevirathne V; Stewart J; Bhagwat AS
Mol Cell Biol; 2019 Jan; 39(1):. PubMed ID: 30348839
[TBL] [Abstract][Full Text] [Related]
47. HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.
Wang Y; Li X; Song S; Sun Y; Zhang J; Yu C; Chen W
Virol J; 2017 Nov; 14(1):211. PubMed ID: 29100527
[TBL] [Abstract][Full Text] [Related]
48. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
[TBL] [Abstract][Full Text] [Related]
49. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
[TBL] [Abstract][Full Text] [Related]
50. Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.
Chen Z; Wen W; Bao J; Kuhs KL; Cai Q; Long J; Shu XO; Zheng W; Guo X
BMC Med Genomics; 2019 Sep; 12(1):131. PubMed ID: 31533728
[TBL] [Abstract][Full Text] [Related]
51. Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion.
Wang X; Li J; Wang Y; Yang B; Wei J; Wu J; Wang R; Huang X; Chen J; Yang L
Nat Biotechnol; 2018 Nov; 36(10):946-949. PubMed ID: 30125268
[TBL] [Abstract][Full Text] [Related]
52. Conservation and Innovation of APOBEC3A Restriction Functions during Primate Evolution.
McLaughlin RN; Gable JT; Wittkopp CJ; Emerman M; Malik HS
Mol Biol Evol; 2016 Aug; 33(8):1889-901. PubMed ID: 27189538
[TBL] [Abstract][Full Text] [Related]
53. Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage.
Suspène R; Mussil B; Laude H; Caval V; Berry N; Bouzidi MS; Thiers V; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2017 Apr; 45(6):3231-3241. PubMed ID: 28100701
[TBL] [Abstract][Full Text] [Related]
54. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
55. Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity.
Green AM; DeWeerd RA; O'Leary DR; Hansen AR; Hayer KE; Kulej K; Dineen AS; Szeto JH; Garcia BA; Weitzman MD
EMBO Rep; 2021 Sep; 22(9):e52145. PubMed ID: 34347354
[TBL] [Abstract][Full Text] [Related]
56. The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS.
Niocel M; Appourchaux R; Nguyen XN; Delpeuch M; Cimarelli A
Sci Rep; 2019 Mar; 9(1):4714. PubMed ID: 30886206
[TBL] [Abstract][Full Text] [Related]
57. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
[TBL] [Abstract][Full Text] [Related]
58. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
59. Single-stranded DNA binding proteins influence APOBEC3A substrate preference.
Brown AL; Collins CD; Thompson S; Coxon M; Mertz TM; Roberts SA
Sci Rep; 2021 Oct; 11(1):21008. PubMed ID: 34697369
[TBL] [Abstract][Full Text] [Related]
60. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
Thielen BK; McNevin JP; McElrath MJ; Hunt BV; Klein KC; Lingappa JR
J Biol Chem; 2010 Sep; 285(36):27753-66. PubMed ID: 20615867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
